Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptors

Summary

Recently a new concept has emerged implicating thrombin signaling as the “bridge” that connects tissue damage to hemostatic and inflammatory responses. In view of this concept, we hypothesized that induction of protease-activated receptor (PAR) expression may play a critical role in endotoxin-induced tissue injury through the cellular actions of thrombin. Thus, in this study, temporal changes in expression of key precoagulant molecules, including PARs, in lungs from rabbits rendered endotoxemic by 100 μg/kg lipopolysaccharide (LPS) were examined with measurements of variables reflecting acute lung injury (ALI). ALI induction by LPS was confirmed by blood gas derangement, lung vascular hyperpermeability, and histopathological changes, and was characterized by the deposition of fibrin in the alveolar spaces, bronchioles and vessels. Plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF) were highly expressed in lungs after LPS injection. While the peaks in levels of PAI-1 and TF were comparable (12∼13-fold from control), their expression time-courses were different: PAI-1 exhibited a bell-shaped expression pattern and peak at 6 h, whereas TF level reached maximum at 10 h. Of note, LPS induced a rapid and significant increase in levels of PAR-1 compared to control, with a peak level at 1 h (3.3-fold). Although declining thereafter, it remained significantly higher than the control level throughout the study period. Expressions of PAR-2, -3, and -4 were also increased by LPS with different time courses from PAR-1 expression. Immunofluorescence staining for PAR-1 were localized in blood vessels, bronchial epithelium, and alveolar pneumocytes after LPS. These results suggest that the increased expression levels of PARs, in addition to PAI-1 and TF, may, in part, underlie the development of ALI occurring during endotoxemia.

Keywords

Acute lung injury - endotoxin - fibrin deposition - plasminogen activator inhibitor-1 - protease-activated receptors - tissue factor - tumor necrosis factor-α

• References

• 1 Cybulsky MI, Chan MKW, Movat HZ. Biology of disease: acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. Lab Invest 1988; 58: 365-78.
• 2 Fourrier F, Chopin C, Goudemand J. et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C and protein S deficiencies. Chest 1992; 101: 816-23.
• 3 Levi M, ten Cate H, van der Poll T. et al. Pathogenesis of disseminated intravascular coagulation in sepsis. J Am Med Assoc 1993; 270: 975-9.
• 4 Voss R, Matthias FR, Borkowski G. et al. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 1990; 75: 99-105.
• 5 Lorente JA, Garcia-Frade LJ, Landin L. et al. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993; 103: 1536-42.
• 6 Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activator after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 320: 1165-72.
• 7 Biemond BJ, Levi M, ten Cate H. et al. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Sci 1995; 88: 587-94.
• 8 Welty-Wolf KE, Carraway MS, Ortel TL. et al. Coagulation and inflammation in acute lung injury. Thromb Haemost 2002; 88: 17-25.
• 9 Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003; 31 [Suppl.]: S213-20.
• 10 Levi M, ten Cate H, Bauer KA. et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93: 114-20.
• 11 Quax PHA, van der Hoogen CM, Verheijen JH. et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissue in vivo. J Biol Chem 1990; 265: 15560-3.
• 12 Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J Clin Invest 1991; 88: 1346-53.
• 13 Fearns C, Thinnes T, Roegner K, Loskutoff DJ. Kinetics of induction of PAI-1 gene expression on liver endothelial cells and hepatocytes by lipopolysaccharide (LPS). Thromb Haemost 1993; 69: 757a (Abstr).
• 14 van der Poll T, Levi M, Büller HR. et al. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991; 174: 729-32.
• 15 Boermeester MA, van Leeuwen PA, Coyle SM. et al. Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis. Arch Surg 1995; 130: 739-48.
• 16 Seki T, Gelehrter TD. Interleukin-1 induction of type-1 plasminogen activator inhibitor (PAI-1) gene expression in the mouse hepatocyte line, AML 12. J Cell Physiol 1996; 168: 648-56.
• 17 Montes R, Rodríguez-Whilhelmi P, Hurtado V. et al. The endotoxin-induced plasminogen activator inhibitor-1 increase in rabbits is not tumor necrosis factor-α dependent and can occur in the absence of interleukin-1β. Thromb Haemost 2002; 88: 639-43.
• 18 Warr TA, Rao LVM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-9.
• 19 Drake TA, Cheng J, Chang A. et al. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142: 1458-70.
• 20 Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Moll Cell Biol 1989; 09: 2752-5.
• 21 Crossman DC, Carr DP, Tuddenham EGD. et al. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265: 9782-7.
• 22 Mackman N, Sawdey MS, Keeton MR. et al. Murine tissue factor gene expression in vivo: tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol 1993; 143: 76-84.
• 23 Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994; 267: L223-41.
• 24 Matsuda N, Hattori Y, Akaishi Y. et al. Impairment of cardiac β-adrenoceptor cellular signaling by decreased expression of G_sα in septic rabbits. Anesthesiology 2000; 93: 1465-73.
• 25 Matsuda N, Hattori Y, Sakuraya F. et al. Hemodynamic significance of histamine synthesis and histamine H₁ ^- and H₂-receptor gene expression during endotoxemia. Naunyn-Schmiedeberg’s Arch Pharmacol 2002; 366: 513-21.
• 26 Matsuda N, Hattori Y, Gando S. et al. Diabetes-induced down-regulation of β₁- adrenoceptor mRNA expression in rat heart. Biochem Pharmacol 1999; 58: 881-5.
• 27 Kopp CW, Hölzenbein T, Steiner S. et al. Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattration and reduced gelatinolytic activity. Blood 2004; 103: 1653-61.
• 28 Haranaka K, Satomi N, Sakurai A. et al. Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int J Cancer 1985; 36: 395-400.
• 29 Partridge CA, Gerritsen ME. Dexamethasone increases the release of three 44 kD proteins immunologically related to plasminogen activator inhibitor-1 from human umbilical vein endothelial and rabbit coronary microvessel endothelial cells. Thromb Res 1990; 57: 139-54.
• 30 Huynh TTT, Davies MG, Thompson MA. et al. Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts. J Vasc Surg 2001; 33: 400-7.
• 31 Lanuza MA, Garcia N, González CM. et al. Role of expression of thrombin receptor PAR-1 in muscle cells and neuromuscular junctions during the synapse elimination period in the neonatal rat. J Neurosci Res 2003; 73: 10-21.
• 32 Copple BL, Moulin F, Hanumegowda UM. et al. Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharideinduced hepatocellular injury in perfused livers. J Pharmacol Exp Ther 2003; 305: 417-425.
• 33 Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986; 133: 913-27.
• 34 Bernard GR, Artigas A, Brigham KL. et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
• 35 Ghofrani HA, Rosseau S, Walmrath D. et al. Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge. Am J Physiol 1996; 270: L62-8.
• 36 Kirchhofer D, Nemerson Y. Initiation of blood coagulation: the tissue factor / factor VIIa complex. Curr Opin Biotechnol 1996; 07: 386-91.
• 37 Hara S, Asada Y, Hatakeyama K. et al. Expression of tissue factor and tissue factor pathway inhibitor in rat lungs with lipopolysaccharide-induced disseminated intravascular coagulation. Lab Invest 1997; 77: 581-9.
• 38 Erlich J, Fearns C, Mathison J. et al. Lipopolysaccharide induction of tissue factor expression in rabbits. Infection Immunity 1999; 67: 2540-6.
• 39 Miller DL, Welty-Wolf K, Carraway MS. et al. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol 2002; 26: 650-8.
• 40 Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost 2001; 86: 298-307.
• 41 Nystedts S, Ramakrishnan V, Sundelin J. The protease-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. J Biol Chem 1996; 27: 14910-5.
• 42 Carla C, Aldo P, Mariarosaria B. et al. Protease-activated receptor-2 involvement in hypertension in normal and endotoxemic rats in vivo. Circulation 1999; 99: 2590-7.
• 43 Patterson C, Stouffer GA, Madamanchi N. et al. New tricks for old dogs. Nonthrombotic effects of thrombin in vessel wall in biology. Circ Res 2001; 88: 987-97.
• 44 O’Brien PJ, Molino M, Kahn M. et al. Protease activated receptors: theme and variations. Oncogene 2001; 20: 1570-81.
• 45 Derian CK, Damiano BP, D’Andrea MR. et al. Thrombin regulation of cell function through protease-activated receptors: implications for therapeutic intervention. Biochemistry (Moscow) 2002; 67: 66-76.